Sfoglia per Autore
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population
2020-01-01 Boffa, G; Bruschi, N; Cellerino, M; Lapucci, C; Novi, G; Sbragia, E; Capello, E; Uccelli, A; Inglese, M.
Ecological impact of isolated cognitive relapses in MS
2020-01-01 Meli, Riccardo; Roccatagliata, Luca; Capello, Elisabetta; Bruschi, Nicolo'; Uccelli, Antonio; Mancardi, Gianluigi; Inglese, Matilde; Pardini, Matteo
Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice
2020-01-01 Bruschi, N.; Boffa, G.; Inglese, M.
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis
2021-01-01 Cellerino, M.; Priano, L.; Bruschi, N.; Boffa, G.; Petracca, M.; Novi, G.; Lapucci, C.; Sbragia, E.; Uccelli, A.; Inglese, M.
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
2021-01-01 Cellerino, M.; Boffa, G.; Lapucci, C.; Tazza, F.; Sbragia, E.; Mancuso, E.; Bruschi, N.; Minguzzi, S.; Ivaldi, F.; Poire, I.; Laroni, A.; Mancardi, G.; Capello, E.; Uccelli, A.; Novi, G.; Inglese, M.
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?
2021-01-01 Tazza, F.; Lapucci, C.; Cellerino, M.; Boffa, G.; Novi, G.; Poire, I.; Mancuso, E.; Bruschi, N.; Sbragia, E.; Laroni, A.; Capello, E.; Inglese, M.
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study
2022-01-01 Cellerino, M; Mancuso, E; Boffa, G; Bruschi, N; Novi, G; Magon, S; Gaetano, L; Uccelli, A; Capello, E; Laroni, A; Lapucci, C; Inglese, M
Improved detection of multiple sclerosis lesions with T2-prepared double inversion recovery at 3T
2022-01-01 Costagli, M.; Lapucci, C.; Zaca, D.; Bruschi, N.; Schiavi, S.; Castellan, L.; Stemmer, A.; Roccatagliata, L.; Inglese, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population | 1-gen-2020 | Boffa, G; Bruschi, N; Cellerino, M; Lapucci, C; Novi, G; Sbragia, E; Capello, E; Uccelli, A; Inglese, M. | |
| Ecological impact of isolated cognitive relapses in MS | 1-gen-2020 | Meli, Riccardo; Roccatagliata, Luca; Capello, Elisabetta; Bruschi, Nicolo'; Uccelli, Antonio; Mancardi, Gianluigi; Inglese, Matilde; Pardini, Matteo | |
| Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice | 1-gen-2020 | Bruschi, N.; Boffa, G.; Inglese, M. | |
| Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis | 1-gen-2021 | Cellerino, M.; Priano, L.; Bruschi, N.; Boffa, G.; Petracca, M.; Novi, G.; Lapucci, C.; Sbragia, E.; Uccelli, A.; Inglese, M. | |
| Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis | 1-gen-2021 | Cellerino, M.; Boffa, G.; Lapucci, C.; Tazza, F.; Sbragia, E.; Mancuso, E.; Bruschi, N.; Minguzzi, S.; Ivaldi, F.; Poire, I.; Laroni, A.; Mancardi, G.; Capello, E.; Uccelli, A.; Novi, G.; Inglese, M. | |
| Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? | 1-gen-2021 | Tazza, F.; Lapucci, C.; Cellerino, M.; Boffa, G.; Novi, G.; Poire, I.; Mancuso, E.; Bruschi, N.; Sbragia, E.; Laroni, A.; Capello, E.; Inglese, M. | |
| Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study | 1-gen-2022 | Cellerino, M; Mancuso, E; Boffa, G; Bruschi, N; Novi, G; Magon, S; Gaetano, L; Uccelli, A; Capello, E; Laroni, A; Lapucci, C; Inglese, M | |
| Improved detection of multiple sclerosis lesions with T2-prepared double inversion recovery at 3T | 1-gen-2022 | Costagli, M.; Lapucci, C.; Zaca, D.; Bruschi, N.; Schiavi, S.; Castellan, L.; Stemmer, A.; Roccatagliata, L.; Inglese, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile